---
schema_version: "secwatch.filing_event.v1"
accession: "0001326190-26-000056"
form_type: "8-K"
ticker: "ALT"
cik: "0001326190"
company_name: "Altimmune, Inc."
filed_at: "2026-09-29T11:03:49+00:00"
generated_at: "2026-10-12T13:41:31.211197+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Altimmune names Richard Menziuso VP, Global Controller and Principal Accounting Officer, effective Sept 29

## Summary
- Richard Menziuso, 51, appointed Vice President, Global Controller and Principal Accounting Officer effective September 29, 2026; CFO Gregory Weaver remains in his role.
- Menziuso was VP, Corporate Controller at Centessa Pharmaceuticals from 2021 until its 2026 acquisition by Eli Lilly; before that North America Controller at Thermo Fisher (2019-2021).
- Earlier roles: VP, Accounting and Controller at Axovant Gene Therapies (2017-2019) and finance positions at LifeCell, ConvaTec, Tyco, PricewaterhouseCoopers and Bristol-Myers Squibb.
- He brings 28 years of finance and accounting experience, including 12 in public accounting, and holds a B.B.A. from Pace University; he is a CPA and Chartered Global Management Accountant.
- Company will enter an indemnification agreement with Menziuso mirroring those for other executive officers; no family relationships or Item 404(a) related-party transactions disclosed.

## SEC filing metadata
- accession: 0001326190-26-000056
- form_type: 8-K
- ticker: ALT
- cik: 0001326190
- company_name: Altimmune, Inc.
- filed_at: 2026-09-29T11:03:49+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1326190/000132619026000056/0001326190-26-000056-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1326190/000132619026000056/alt-20260924x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001326190-26-000056
- JSON: https://secwatch.observer/filing/0001326190-26-000056.json
- Plain text: https://secwatch.observer/filing/0001326190-26-000056.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.